Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA ·

Keywords

ClinConnect Summary

This clinical trial is studying treatment options and patient experiences for people diagnosed with early-stage breast cancer who are considered high-risk, meaning their cancer has certain features that may make it more likely to come back. The study aims to understand what treatments patients are receiving in real life and how these treatments affect their quality of life. Participants will be patients already receiving treatment as part of their regular care, and they will be asked to fill out questionnaires about their health and well-being over time.

Anyone diagnosed with early breast cancer who falls into the high-risk group and is between the ages of 65 and 74 may be eligible to join. Both men and women can participate. Once enrolled, patients will be followed for up to five years, with regular check-ins to gather information about their treatments and how they are feeling physically and emotionally. This study is observational, which means it does not change the treatments patients receive but focuses on learning from their real-world experiences to help improve care in the future.

Gender

ALL

Eligibility criteria